Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Research Progress on Application of CRISPR/Cas Genome Editing Technology in Hematological Diseases -Review].

Zhongguo shi yan xue ye xue za zhi - 1 Aug 2016

Xin Liu-Yan, Liu Ai-Fei, Zhong Si-Si, Chen Yi-Jian

Abstract excerpt

CRISPR/Cas genome editing technology is a newly developed powerful tool for genetic manipulation, which can be used to manipulate the genome at specific locations precisely, to restore the function of genetic defect cells, and to develop various disease models. In recentl years, with the advances of precise genome manipulation, CRISPR/Cas technology has been applied to many aspects of diseases research and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR-Cas Systems
Share to Gene Editing
Share to Genetic Techniques

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genome

Share to Hematologic Diseases

Share to Phenotype

Source

Identifiers

PMID: 27531817
DOI: 10.7534/j.issn.1009-2137.2016.04.061

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Research Progress on Application of CRISPR/Cas Genome Editing Technology in Hematological Diseases -Review].PMID 27531817Read ↗

Advances in therapeutic application of CRISPR-Cas9Semantic proximity Read ↗

CRISPR ‐Cas9 technology and its application in haematological disordersSemantic proximity Read ↗

Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review)Semantic proximity Read ↗

Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicineSemantic proximity Read ↗

The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies.Semantic proximity Read ↗

CRISPR RNA-Guided Gene Editing and its Clinical Research Applications in Hematology with Focus on Inherited Germline Predisposition to Hematologic MalignanciesSemantic proximity Read ↗

An introduction to CRISPR-Cas systems for reprogramming the genome of mammalian cells.Semantic proximity Read ↗

CRISPR-Cas9 for treating hereditary diseases.Semantic proximity Read ↗

Crispr-cas System: Classification, Benefits, Applications And FunctionSemantic proximity Read ↗

Progress and Perspective of CRISPR‐Cas9 Technology in Translational MedicineSemantic proximity Read ↗

CRISPR Editing in Biological and Biomedical Investigation.Semantic proximity Read ↗

CRISPR to fix bad blood: a new tool in basic and clinical hematologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.